24.10.2017
- The US Food and Drug Administration on Oct. 20 approved Shingrix, the long awaited recombinant, adjuvant new shingles vaccine manufactured by UK drugmaker Glaxo SmithKline (GSK)...
18.10.2017
- As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...
26.07.2017
- US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...
10.07.2017
- UK drugmaker GlaxoSmithKline (GSK) is to collaborate with artificial intelligence (AI) company Exscientia. The partnership will see Exscientia combine its AI-enabled platform with...
03.05.2017
- Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
29.03.2017
- UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...
13.03.2017
- After acquiring the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, last year in a drive to be a major player...
